Revenues in the second quarter totaled $9.23 billion, up 9.2 percent from $8.45 billion in the second quarter of 2013. Adjusted EBITDA also increased by 18.5 percent, from $1.69 billion in the second quarter of 2013 to $2 billion this year. Same-facility revenue per equivalent admission also increased 5.4 percent in the second quarter of this year.
For the six months ended June 30, HCA reported $830 million in net income, up 8 percent from $767 million in the first six months of 2013. Revenues during the first six months of 2014 also increased by about 1 percent, from $16.89 billion during the first half of 2013 to $18.06 billion this year. Adjusted EBITDA for the six months ended June 30 was $3.64 billion, up nearly 12 percent year-over-year from $3.26 billion.
More articles on HCA:
HCA appoints Chris Taylor as Parallon president
For-profit hospital stock report: Week of July 21-25, 2014
HCA anticipates 9% rise in Q2 revenue
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
